BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 35 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,975 | -20.3% | 0.00% | – |
| Q2 2023 | $5,000 | 0.0% | 2,478 | +61.6% | 0.00% | – |
| Q1 2023 | $5,000 | +66.7% | 1,533 | 0.0% | 0.00% | – |
| Q4 2022 | $3,000 | -57.1% | 1,533 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 1,533 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,533 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -16.7% | 1,533 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | +20.0% | 1,533 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 1,533 | -18.1% | 0.00% | – |
| Q2 2021 | $7,000 | -81.1% | 1,872 | -80.2% | 0.00% | – |
| Q1 2021 | $37,000 | -32.7% | 9,436 | -21.3% | 0.00% | – |
| Q4 2020 | $55,000 | -71.1% | 11,988 | +6.7% | 0.00% | – |
| Q3 2020 | $190,000 | +31.0% | 11,231 | -13.1% | 0.00% | – |
| Q2 2020 | $145,000 | +145.8% | 12,931 | +1.5% | 0.00% | – |
| Q1 2020 | $59,000 | +40.5% | 12,741 | +30.1% | 0.00% | – |
| Q4 2019 | $42,000 | +7.7% | 9,796 | -3.4% | 0.00% | – |
| Q3 2019 | $39,000 | 0.0% | 10,143 | +3.5% | 0.00% | – |
| Q2 2019 | $39,000 | -7.1% | 9,796 | 0.0% | 0.00% | – |
| Q1 2019 | $42,000 | +23.5% | 9,796 | +2.8% | 0.00% | – |
| Q4 2018 | $34,000 | -5.6% | 9,533 | -0.4% | 0.00% | – |
| Q3 2018 | $36,000 | -2.7% | 9,575 | +0.4% | 0.00% | – |
| Q2 2018 | $37,000 | +23.3% | 9,533 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +66.7% | 9,533 | +110.3% | 0.00% | – |
| Q4 2017 | $18,000 | 0.0% | 4,533 | -0.2% | 0.00% | – |
| Q3 2017 | $18,000 | +5.9% | 4,544 | +12.7% | 0.00% | – |
| Q2 2017 | $17,000 | 0.0% | 4,033 | 0.0% | 0.00% | – |
| Q1 2017 | $17,000 | +183.3% | 4,033 | +59.2% | 0.00% | – |
| Q4 2016 | $6,000 | -78.6% | 2,533 | -78.0% | 0.00% | – |
| Q3 2016 | $28,000 | 0.0% | 11,533 | 0.0% | 0.00% | – |
| Q2 2016 | $28,000 | -6.7% | 11,533 | 0.0% | 0.00% | – |
| Q1 2016 | $30,000 | +3.4% | 11,533 | +15.0% | 0.00% | – |
| Q4 2015 | $29,000 | +81.2% | 10,033 | +42.7% | 0.00% | – |
| Q3 2015 | $16,000 | +300.0% | 7,033 | +580.8% | 0.00% | – |
| Q2 2015 | $4,000 | 0.0% | 1,033 | 0.0% | 0.00% | – |
| Q1 2015 | $4,000 | -20.0% | 1,033 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | +150.0% | 1,033 | +93.8% | 0.00% | – |
| Q3 2014 | $2,000 | – | 533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 189,935 | $311,494 | 0.08% |
| ABNER HERRMAN & BROCK LLC | 280,000 | $459 | 0.07% |
| Weaver Consulting Group | 65,947 | $108,153 | 0.06% |
| S.C. Financial Services, Inc. | 25,372 | $41,610 | 0.03% |
| JMAC ENTERPRISES LLC | 40,430 | $66,305 | 0.02% |
| Weaver Consulting Group | 53,500 | $10,047 | 0.01% |
| IFP Advisors, Inc | 26,650 | $139 | 0.00% |
| Bangor Savings Bank | 4,000 | $7 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $4,920 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 19,098 | $31,321 | 0.00% |